AGC Biologics Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility
September 13, 2021 19:57 ET
|
AGC Biologics
Heidelberg, Germany, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced expansion plans...
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO
September 09, 2021 08:30 ET
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty...
Roberto Almodóvar Febles Joins Pii as Head of Aseptic Operations
August 31, 2021 08:00 ET
|
Pharmaceutics International Inc.
Hunt Valley, Maryland, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Roberto Almodóvar Febles becomes Head of Aseptic Operations at Pharmaceutical International, Inc. (Pii) where he will oversee and manage...
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
August 24, 2021 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company’s Chief Accounting...
Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
August 18, 2021 08:30 ET
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO...
Processa Pharmaceuticals Announces Second Quarter 2021 Results and Provides Corporate Update
August 12, 2021 17:15 ET
|
Processa Pharmaceuticals, Inc.
Adds fourth clinical asset, RX-3117, and targets major milestones in the second half of 2021 HANOVER, Md., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a...
Biofrontera AG: Conference call to discuss half-year 2021 financial results to be held on August 20, 2021
August 12, 2021 08:55 ET
|
Biofrontera AG
Leverkusen, Germany, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Global CRISPR Technology Market Size to Grow at a CAGR of 23.8% from 2021 to 2030
August 11, 2021 07:00 ET
|
Quince Market Insights
Pune, India, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The CRISPR Technology Market is expected to value USD 900.21 million in 2021 and is projected to grow at a CAGR of 23.8 % during the forecast period....
ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System
August 10, 2021 16:30 ET
|
ADMA Biologics, Inc.
RAMSEY, N.J. and BOCA RATON, Fla. and CONYERS, Ga., Aug. 10, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to...
Aeterna Zentaris Reports Second Quarter 2021 Financial Results and Provides Pipeline Program Updates
August 04, 2021 16:05 ET
|
Aeterna Zentaris Inc
– Company continues to advance clinical and preclinical programs with its diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need – Strong...